1. Background {#sec110736}
=============

The burn wound provides suitable conditions for bacterial growth. Bacterial infection is a serious factor of mortality in burn patients. Incidentally, approximately 75% of the mortality due to burn wounds is associated with infections ([@A18352R1]). An opportunistic, nosocomial pathogen of immunocompromised patients, *Pseudomonas aeruginosa,* typically infects the burn wounds. A study revealed that *P. aeruginosa* was isolated from 73.9% of the burn patients in Iran ([@A18352R2], [@A18352R3]). In addition, many studies showed that colonization of these bacteria in burn wounds is a main cause of mortality in burn patients in burn treatment centers in Iran ([@A18352R2]).

To treat such infections, carbapenems such as imipenem are identified as the most effective agent against *P. aeruginosa* ([@A18352R4]). Although imipenem is known as a potential last treatment option for patients with burn lesions, it was revealed that one of the most concerning characteristics of *P. aeruginosa* species is their high resistance to imipenem in hospitalized burn patients in recent years. were reported 16% - 100% in Tehran hospitals in various studies ([@A18352R5]).

Although metallo-β-lactamases (MBLs) are one of the most important mechanisms resulting in treatment failure in carbapenem therapy of *P. aeruginosa* infections, these isolates also produce β-lactamases of class A and D. Class A extended-spectrum β-lactamases (ESBLs) including TEM, SHV, GES, PER, VEB, CTX-M and IBC families are also found in *P. aeruginosa* strains. extended-spectrum β-lactamases from the class D, OXA-type enzymes are also detected in *P. aeruginosa* ([@A18352R6]). Also recently, the number of *P. aeruginosa* isolates producing KPC-type carbapenemases raised significantly ([@A18352R7]). Plasmid acquired Ambler class A ESBLs such as GES, PER, SHV and TEM types were normally found in *Entrobacteriaceae*. Class A ESBLs are recently identified in *P. aeruginosa* but they are reported in a limited areas ([@A18352R8]). Compared with the enterobacterial species, in which TEM and SHV ESBLs are found most frequently, OXA and PSE types are the most common β-lactamases in *P. aeruginosa* ([@A18352R9]).

2. Objectives {#sec110737}
=============

To the best of the authors\` knowledge, there is not enough information regarding the prevalence of class A and D ESBLs and the type of involved genes in imipenem resistant *P. aeruginosa* in burn patients in Iran. The current study aimed to investigate the prevalence of GES, PER, SHV, TEM and OXA-10 ESBLs as well as KPC carbapenemases among imipenem resistant *P. aeruginosa* strains isolated from the burn patients hospitalized in several burn treatment centers in Tehran, Iran ([@A18352R2]).

3. Patients and Methods {#sec110741}
=======================

3.1. Bacterial Isolates {#sec110738}
-----------------------

Fifty imipenem resistant *P. aeruginosa* species were isolated from hospitalized burn patients from 2009 to 2010 in Tehran, Iran. The isolates were identified as *P. aeruginosa* by conventional biochemical tests such as oxidase and catalase production, growth at 42ºC, and production of pigment on Mueller-Hinton agar (Merck, Germany). The isolates were stored at -20ºC in brain-heart infusion broth (Merck, Germany) with 15% glycerol for future investigations.

3.2. Susceptibility Tests and Confirmation of ESBLs Production {#sec110739}
--------------------------------------------------------------

Antimicrobial susceptibility to various antibiotics was carried out using the disc-diffusion method recommended by the clinical and laboratory standards institute (CLSI) guidelines ([@A18352R10]). Eleven antibacterial discs including cefotaxime (CTX; 30 µg), ceftazidime (CAZ; 30 µg), aztreonam (ATM; 30 µg), gentamicin (GM; 10 µg), ciprofloxacin (CIP; 5 µg), amikacin (AN; 30 µg), tobramycin (TOB; 10 µg), cefepime (CPM; 30 µg), pipracillin (PIP; 100 µg), cefixime (CFM; 5 µg), and ticarcillin (TIC; 75 µg) (MAST, UK) were used. ESBLs phenotypic confirmatory tests were performed by combined disc tests, using CTX and CTX/clavulanic acid (30/10 µg) and CAZ and CAZ/clavulanic acid (30/10 µg) ([@A18352R11]). The inhibitory zone diameter ≥ 5 mm was considered positive for ESBLs production.

3.3. Detection of blaGES, blaPER, blaSHV, blaTEM, blaOXA-10 and blaKPC Genes by Polymerase Chain Reaction {#sec110740}
---------------------------------------------------------------------------------------------------------

DNA was extracted by the boiling method ([@A18352R12]) and PCR analysis was carried out on all 50 isolates to evaluate the prevalence of the *bla*~*GES*~, *bla*~*PER*~, *bla*~*SHV*~, *bla*~*TEM*~, *bla*~*OXA-10*~ ESBLs and *bla*~*KPC*~ carbapenemases genes. The DNA amplification program and the specific primers (TAKAPOUZIST, IRAN) used for standard PCR amplification procedures are shown in [Table 1](#tbl28466){ref-type="table"} ([@A18352R11], [@A18352R13]-[@A18352R17]). To detect DNA fragments PCR products were detected by gel electrophoresis in 1.5% agarose.

###### The DNA Amplification Program and the Specific Primers Used for Standard PCR Procedure

  Target       Primer Sequence                         Amplicon Size, bp   Initial Denaturation   Second Denaturation                           Annealing Stage, for 1 min   First Extension   Last Extension
  ------------ --------------------------------------- ------------------- ---------------------- --------------------------------------------- ---------------------------- ----------------- -----------------
  **GES**                                                                  94ºC for 4 min         35 cycles of denaturation at 94ºC for 1 min   60ºC                         72ºC for 1 min    72ºC for 10 min
               F (5'-ATGCGCTTCATTCACGCAC-3')           864                                                                                                                                     
               R (5'-CTATTTGTCCGTGCTCAGG -3')                                                                                                                                                  
  **PER**                                                                  94ºC for 4 min         35 cycles of denaturation at 94ºC for 1 min   55ºC                         72ºC for 1 min    72ºC for 10 min
               F (5'-ATG AAT GTC ATT ATA AAA GC -3')   925                                                                                                                                     
               R (5'-AAT TTG GGC TTA GGG CAG AA-3')                                                                                                                                            
  **SHV**                                                                  94ºC for 4 min         35 cycles of denaturation at 94ºC for 1 min   58ºC                         72ºC for 1 min    72ºC for 10 min
               F(5'-AAGATCCACTATCGCCAGCAG-3')          231                                                                                                                                     
               R (5'-ATTCAGTTCCGTTTCCCAGCGG-3')                                                                                                                                                
  **TEM**                                                                  94ºC for 4 min         35 cycles of denaturation at 94ºC for 1 min   55ºC                         72ºC for 1 min    72ºC for 10 min
               F (5'-ATGAGT ATTCAACATTTCCG-3')         858                                                                                                                                     
               R (5'-CCAATGCTTAATCAGTGAGG-3')                                                                                                                                                  
  **OXA-10**                                                               94ºC for 4 min                                                       58ºC                         72ºC for 1 min    72ºC for 10 min
               F (5'-TCAACAAATCGCCAGAGAAG-3')          276                                                                                                                                     
               R (5'-TCCCACACCAGAAAAACCAG-3')                                                                                                                                                  
  **KPC**                                                                  94ºC for 4 min         35 cycles of denaturation at 94ºC for 1 min   52ºC                         72ºC for 1 min    72ºC for 10 min
               F (5'-ATGTCACTGTATCGCCGTCT-3')          893                                                                                                                                     
               R (5'-TTTTCAGAGCCTTACTGCCC-3')                                                                                                                                                  

4. Results {#sec110742}
==========

The results of antibiogram testing showed that all isolates (100%) were resistant to CTX, CPM, PIP, CFM and TIC. Meanwhile, the findings revealed that 49 (98%) isolates were resistant to CAZ, CIP and 48 (96%) isolates were resistant to ATM, AN, GM and TOB. Most of the isolates were resistant to various classes of antibacterial agents ([Table 2](#tbl28467){ref-type="table"}). Among the 50 isolates, 44 (88%) were multi-drug resistant and phenotypic tests indicated that 27 (54%) strains were presumed ESBLs producers. Among the 27 strains, 23 (85.18%) were determined with zone diameters of 5 - 14 mm in combination with CAZ/clavulanic acid and 17 (62.96%) were determined with zone diameters of 5 - 12 mm in combination with CTX/clavulanic acid.

###### Relationship Between Antibacterial Pattern and Imipenem Resistant Isolates Carrying ESBLs Genes Alone ^[a](#fn27882){ref-type="table-fn"}^

  Antibiotics   Antibiotic Resistant Isolates Carrying ESBLs Genes Alone               
  ------------- ---------------------------------------------------------- ----- ----- -----
  **CTX**       100                                                        100   100   100
  **CAZ**       100                                                        100   100   100
  **ATM**       100                                                        100   100   100
  **GM**        98                                                         100   100   100
  **CIP**       100                                                        98    98    100
  **AN**        98                                                         100   100   100
  **TOB**       98                                                         100   100   100
  **CPM**       100                                                        100   100   100
  **PIP**       100                                                        100   100   100
  **CFM**       100                                                        100   100   100
  **TIC**       100                                                        100   100   100

^a^ Abbreviations: AN, amikacin; ATM, aztreonam; CAZ, ceftazidime; CFM, cefixime; CIP, ciprofloxacin; CPM, cefepime; CTX, cefotaxime; GM, gentamicin; PIP, pipracillin; R, resistant; TIC, ticarcillin; TOB, tobramycin.

PCR analysis was carried out for all 50 isolates using primers specific to *bla*~*PER*~, *bla*~*GES*~, *bla*~*OXA-10*~, *bla*~*TEM*~, *bla*~*SHV*~ and *bla*~*KPC*~. Four of six genes were detected alone or in various combinations; 7 (14%), 18 (36%), 18 (36%), 18 (36%) strains of a total of 50 isolates were amplified as *bla*~*PER*~, *bla*~*OXA-10*~, *bla*~*TEM*~ and *bla*~*SHV*~, respectively ([Figure 1](#fig21147){ref-type="fig"}). Whilst among the 27 isolates indicated as presumed ESBLs producers phenotypically, 3 (11.11%), 12 (42.85%), 14 (50%) and 14 (50%) strains were detected as *bla*~*PER*~, blaOXA-10, *bla*~*TEM*~ and *bla*~*SHV*~ genes, respectively. In addition, among isolates, 10 (20%) carried *bla*~*TEM*~, bla~OXA-10~ and *bla*~*SHV*~ genes, simultaneously. Also 98% of SHV, TEM and OXA-10 producing strains were resistant to all of the antibiotics used in this research. No *bla*~*KPC*~ and *bla*~*GES*~ genes were detected in the study. [Table 3](#tbl28468){ref-type="table"} shows that approximately all of the isolates harboring multiple antimicrobial resistance genes were 100% resistant to different classes of antibiotics except CIP.

![Electrophoresis of PCR Products for Amplifying *bla*~*GES*~, *bla*~*PER*~, *bla*~*SHV*~, *bla*~*TEM*~, *bla*~*OXA-10*~ and *bla*~*KPC*~ Genes\
No 1, DNA marker (100 kb). No 2, *bla*~*SHV*~ (231 bp), No 3, *bla*~*TEM*~ (858 bp), No 4, *bla*~*OXA-10*~ (276), No 5, positive control for *bla*~*GES*~ (864 bp), No 6, positive control for *bla*~*KPC*~ (893 bp), No 7, *bla*~*PER*~ (925 bp).](jjm-08-08-18352-g001){#fig21147}

###### Relationship Between Antibacterial Pattern and Imipenem Resistant Isolates Carrying ESBLs Genes in Various Combinations ^[a](#fn27883){ref-type="table-fn"}^

  Antibiotics   Resistant Isolates Carrying ESBL Genes   
  ------------- ---------------------------------------- -----
  **CTX**       100                                      100
  **CAZ**       100                                      100
  **ATM**       100                                      100
  **GM**        100                                      100
  **CIP**       6.25                                     100
  **AN**        100                                      100
  **TOB**       100                                      100
  **CPM**       100                                      100
  **PIP**       100                                      100
  **CFM**       100                                      100
  **TIC**       100                                      100

^a^ Abbreviations: AN, amikacin; ATM, aztreonam; CAZ, ceftazidime; CIP, ciprofloxacin; CFM, cefixime; CPM, cefepime; CTX, cefotaxime; GM, gentamicin; TOB, tobramycin; PIP, pipracillin; TIC, ticarcillin.

5. Discussion {#sec110743}
=============

The application of antibiotics is one of the most important scientific attainments of the 20th century. However, prevalent antibiotic use increases antibiotic-resistant pathogens, including multidrug resistant isolates ([@A18352R18]). Antibiotic resistance of pathogenic bacteria is a major global danger and Realization of the resistance mechanisms is critical to development of novel therapeutic options ([@A18352R18]). *Pseudomonas aeruginosa* is the predominant bacterial pathogen in patients with burn injuries. The resistance of this microorganism to antibiotics is a worrisome problem in hospitalized patients with burn injuries. Extended spectrum β-lactamases, carbapenemases, metallo β-lactamases and AmpC β-lactamases producing organisms are the main problems to treat the infected burn patients in burn centers ([@A18352R1]). One of the most important ways to select an effective method to reduce such infections is specifying the relationship between genotype and drug susceptibility ([@A18352R1]). Multidrug-resistant *P. aeruginosa* isolates re a worrying matter from burn patients in Iran ([@A18352R19]). Several classes of ESBLs such as OXA, PER, TEM, SHV and GES are newly detected in *P. aeruginosa*. Also recently, the number of *P. aeruginosa* isolates producing KPC-type carbapenemases has significantly raised ([@A18352R7]).

The findings of the present study explained that high levels of resistance to many antimicrobial antibiotics existed among *P. aeruginosa* isolated from the infected wounds of burn patients and the majority of isolates (88%) were multi-drug resistant. All isolates were totally resistant to CTX, CPM, PIP, CFM and TIC; whereas the minimum resistance rate (96%) was demonstrated for ATM, GM, TOB and AN. Results of the previous studies approved resistance to a large number of antibiotics usually used to treat burn injuries caused by *P. aeruginosa* in the Iranian hospitals ([@A18352R19]). For instance, Shahcheraghi et al. reported that nosocomial *P. aeruginosa* isolates were resistant to cefotaxime (56%) and ceftazidime (25%) ([@A18352R20]). In another study, the rates of resistance were as follows: ceftazidime (74.8%) and cefotaxime (50.4%) ([@A18352R19]). Moreover, among 27 isolates, phenotypically positive for ESBLs production, 0 (0%), 12 (42.85%), 14 (50%) and 14 (50%) strains were detected as *bla*~*PER*~, *bla*~*OXA-10*~, *bla*~*TEM*~ and *bla*~*SHV*~ genes, respectively. Shahcheraghi et al. reported that the frequency of *bla*~*PER*~, *bla*~*TEM*~, *bla*~*SHV*~ and *bla*~*GES*~ were 17%, 9%, 22% and 0%, respectively ([@A18352R20]).

To find more information about the prevalence and type of the relevant genes involved in the multi-drug resistance of nosocomial *P. aeruginosa* isolates, the PCR experiments were performed for all 50 isolates. Of the 50 isolates, 7 (14%), 18 (36%), 18 (36%) and18 (36%) strains were positive for *bla*~*PER*~, *bla*~*OXA-10*~, *bla*~*TEM*~ and *bla*~*SHV*~ alone or in various combinations, respectively. In addition, earlier reports from Iran also showed that the prevalence of *bla*~*PER-1*~ and *bla*~*OXA-10*~ were 49.25% and 74.62%, respectively ([@A18352R2]). The observations suggest that the prevalence of *bla*~*OXA-10*~, *bla*~*TEM*~ and *bla*~*SHV*~ among all of the 50 isolates were relatively high in the present work. Except in Turkey, in which PER (86%) and OXA-10 (55%) as well as Saudi Arabia in which OXA-10 (56%) and GES (20%) producing *P. aeruginosa* strains were reported ([@A18352R21], [@A18352R22]), no current data existed on the real prevalence of these genes in the countries neighboring Iran. It is possible that the distribution of PER and OXA-10 probably associated with the immigration and traveling between Iran and Turkey.

A study conducted in Taiwan showed that TEM, SHV-18 and OXA-10 genes exist in 100%, 91.3% and 21.7% of the total *P. aeruginosa* strains, respectively ([@A18352R23]). Based on the results of PCR assay, there were no *bla*~*GES*~ and *bla*~*KPC*~ genes in the 50 tested isolates of *P. aeruginosa* in the current study. There are several case reports on the isolation of KPC-producing *P. aeruginosa* and *Klebsiella* species in burned patients in Iran ([@A18352R24], [@A18352R25]). There seems to be a gradual increase in KPC-producing *P. aeruginosa* in the burn centers of Iran. From the clinical point of view, occurrence of KPC-producer Gram-negative bacteria among the burned patients causes a much higher degree of resistance to many antibacterial agents including β-lactams, quinolones and aminoglycosides ([@A18352R26]). These findings increase the concern about the future of antibiotic therapy for KPC-producing *P. aeruginosa* strains.

In conclusion, the current study described that the high rates of resistance to different antibacterial agents and a gradual increase in the degree of PER, OXA-10, SHV and TEM ESBLs among the majority of imipenem resistant *P. aeruginosa* isolated from the burn patients with infected wounds is an enormous threat in burn centers of Iran. Therefore, molecular epidemiologic studies play a significant role in the evaluation of transmission ways of the pathogen for infection control.
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